OphthaConsulting

Ophthalmology Practice Valuation in 2026: What Your Practice Is Actually Worth

2026 ophthalmology practice valuations range from 4x to 9x EBITDA depending on specialty mix, operational quality, and buyer type. Here

Diana AndreFounder · Lead Consultant · March 3, 2026

Private equity continues to view ophthalmology as one of the most attractive physician practice segments in 2026. Here's how practices are valued, what drives premium multiples, and how operational excellence directly affects your sale price.

  • Ophthalmology practice valuation 2026 is one of the most impactful areas for ophthalmology practice transformation.
  • Evidence-based systems — not one-off fixes — produce lasting operational improvements.
  • Top-performing practices in Southern California address practice strategy as a strategic priority, not an afterthought.
  • Ophtha-Consulting's 90-day framework has helped practices move from reactive crisis management to proactive operational excellence.

Whether you're planning to sell in 12 months or 12 years, understanding how your ophthalmology practice is valued creates decisions worth hundreds of thousands — sometimes millions — of dollars. The practices that receive the highest valuations in 2026 aren't necessarily the busiest or the most clinically distinguished. They're the most operationally excellent — and that distinction is something a consultant can measurably improve before you go to market.

How Ophthalmology Practices Are Valued in 2026

The dominant valuation methodology for ophthalmology practices in private equity and strategic buyer transactions is an EBITDA multiple — Earnings Before Interest, Taxes, Depreciation, and Amortization, multiplied by a market-determined factor.

Current 2026 EBITDA multiple ranges by practice type:

  • General ophthalmology (single physician): 4x–5.5x EBITDA
  • General ophthalmology (multi-physician group): 5x–7x EBITDA
  • Cataract/refractive surgical focus: 6x–8x EBITDA
  • Retina subspecialty practice: 7x–9x EBITDA
  • Large multi-location groups: 8x–11x EBITDA (platform premium)

What Drives Premium Multiples

Within each category, there's significant multiple variation based on operational factors that directly affect a buyer's risk assessment and growth potential projection:

Clean, Documented Operations

Buyers apply a risk discount to practices with operational chaos — high staff turnover, inconsistent billing, patient satisfaction problems. A practice with documented SOPs, stable staff, and consistent KPI performance commands a premium multiple because the buyer can project future performance with confidence.

Revenue Quality and Diversification

Practices heavily dependent on a single revenue source (e.g., 80%+ from insurance-reimbursed exams) receive lower multiples than practices with diversified revenue — surgical fees, premium IOL upgrades, dry eye programs, optical dispensing. Revenue diversity reduces concentration risk and typically indicates higher revenue per patient.

Staff Independence from the Physician

The most common value destroyer in ophthalmology practice sales: practices where the physician is the practice — where patient relationships, referral relationships, and daily operations are so physician-dependent that the business has no standalone value. Buyers pay premium multiples for practices with strong operational teams, documented processes, and patient loyalty systems that don't require the selling physician's continued presence.

Growth Trajectory

A practice with 3 years of revenue growth commands a higher multiple than a flat or declining practice. Buyers pay for momentum. If your practice is planning a sale in 3–5 years, implementing growth initiatives now — dry eye programs, premium IOL optimization, a recall system — creates the growth trajectory that maximizes your multiple.

The Operational Investment That Pays at Exit

Every dollar of EBITDA improvement generates $5–$8 in enterprise value at current multiples. A practice that invests $50,000 in operational consulting over 12 months and generates $100,000 in EBITDA improvement has created $500,000–$800,000 in additional enterprise value. The ROI math on pre-sale operational optimization is one of the most compelling in all of practice management.

Understanding your practice's current valuation — and what operational changes would most efficiently increase it — is a strategic conversation worth having well before you're ready to sell. Ophtha-Consulting strategy consulting includes practice valuation assessment and a prioritized roadmap to maximize enterprise value.

Ophtha-Consulting

Ophthalmology Practice Consultant · Clinical Operations Specialist

Ophtha-Consulting brings 25+ years of direct ophthalmology practice experience across Southern California and New York. The operational observations in this article draw on active clinical work and the patterns documented across eight ophthalmology practices since 1998.

About the Methodology

When this article describes operational patterns as common, frequent, or typical, the characterization reflects Diana's direct clinical observations across 25+ years and eight ophthalmology practices, including daily patient and physician interactions accumulated over more than 50,000 working hours of in-clinic experience. The methodology is lived professional experience, not statistical research. Where specific patterns are described, they reflect what Diana has observed in her clinical and consulting practice — not validated survey research, not peer-reviewed data, not third-party industry studies.

Healthcare consulting websites frequently cite proprietary internal data as the foundation for percentage claims that are difficult to verify. The observations on this blog are grounded in lived clinical experience across 25 years and eight practices — a legitimate consulting foundation, presented as what it is rather than dressed up as statistical research.

Diana is available for 30-minute discovery calls with practice owners considering operational consulting engagements. The discovery call is free, has no commitment attached, and ends with an honest assessment of whether her service areas match the practice's situation.

Schedule a Discovery Call

Free 30-minute call with practice owners. No commitment. Honest assessment of whether Diana's service areas fit your situation.

About the author

Diana AndreFounder · Lead Consultant

Diana Andre has been a W-2 employee inside ophthalmology practices since 1998. Eight practices, 25+ years of active, in-practice experience across solo, small-group, and multi-specialty ophthalmology operations.

Schedule the call

A 30-minute discovery call is free and has no commitment attached.

Ophtha-Consulting personally responds within one business day. Calls are scheduled around clinical hours.

Book Discovery Call